<div id="readability-page-1"><div><p>In March 2026, global markets have been navigating a complex landscape marked by geopolitical tensions in the Middle East and fluctuating energy prices, leading to mixed performances across key indices. While large-cap stocks face pressure, small- and mid-cap indexes like the S&amp;P MidCap 400 and Russell 2000 have shown resilience, highlighting potential opportunities for investors seeking undiscovered gems. In such an environment, identifying stocks with strong fundamentals that can withstand economic uncertainties becomes crucial for long-term growth potential.</p><h3>Top 10 Undiscovered Gems With Strong Fundamentals Globally</h3><div><table><tbody><tr><th>Name</th><th>Debt To Equity</th><th>Revenue Growth</th><th>Earnings Growth</th><th>Health Rating</th></tr><tr><td>Asian Terminals</td><td>25.82%</td><td>12.05%</td><td>17.00%</td><td>★★★★★★</td></tr><tr><td>VICOM</td><td>NA</td><td>9.48%</td><td>7.34%</td><td>★★★★★★</td></tr><tr><td>Saha-Union</td><td>1.08%</td><td>0.23%</td><td>18.09%</td><td>★★★★★★</td></tr><tr><td>Natural Food International Holding</td><td>NA</td><td>8.04%</td><td>37.71%</td><td>★★★★★★</td></tr><tr><td>Daphne International Holdings</td><td>NA</td><td>19.20%</td><td>59.40%</td><td>★★★★★★</td></tr><tr><td>ADDCN Technology</td><td>16.11%</td><td>8.80%</td><td>6.18%</td><td>★★★★★☆</td></tr><tr><td>Palasino Holdings</td><td>8.57%</td><td>4.07%</td><td>-18.45%</td><td>★★★★★☆</td></tr><tr><td>Fengyinhe Holdings</td><td>9.39%</td><td>53.36%</td><td>74.10%</td><td>★★★★☆☆</td></tr><tr><td>Procimmo Group</td><td>141.47%</td><td>6.84%</td><td>6.01%</td><td>★★★★☆☆</td></tr><tr><td>Etihad GO Telecom</td><td>NA</td><td>38.31%</td><td>54.97%</td><td>★★★★☆☆</td></tr></tbody></table></div><p> Click here to see the full list of 3100 stocks from our Global Undiscovered Gems With Strong Fundamentals screener.     </p><p>Underneath we present a selection of stocks filtered out by our screen.</p><h2>Aurisco PharmaceuticalLtd (SHSE:605116)</h2><p><strong>Simply Wall St Value Rating:</strong> ★★★★★☆</p><p><strong>Overview:</strong> Aurisco Pharmaceutical Co., Ltd. is involved in the global research, development, production, and sales of special complex active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and preparations, with a market capitalization of CN¥10.85 billion.</p><p><strong>Operations:</strong> Aurisco generates revenue primarily from the sale of complex active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and preparations. The company's market capitalization is CN¥10.85 billion.</p><p>Aurisco Pharmaceutical, a small cap player in the pharma sector, has shown robust financial health with a debt to equity ratio climbing to 37.7% over five years, yet its interest payments are comfortably covered 33 times by EBIT. The company boasts high-quality earnings and an impressive earnings growth of 24.6% last year, outpacing the industry average of 8.1%. Its price-to-earnings ratio stands at 28.1x compared to the broader CN market's 45.2x, suggesting good value potential. Recently, Aurisco completed a share buyback program repurchasing over 2 million shares for CNY 60 million as of early January this year.</p><ul><li>Navigate through the intricacies of Aurisco PharmaceuticalLtd with our comprehensive health report here.</li><li>Evaluate Aurisco PharmaceuticalLtd's historical performance by accessing our past performance report.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9343dee9-a005-457f-8e89-30f175b4b31c/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9343dee9-a005-457f-8e89-30f175b4b31c/chart/debt-equity-history-analysis"/><figcaption>SHSE:605116 Debt to Equity as at Mar 2026</figcaption></figure><h2>Qingdao NovelBeam TechnologyLtd (SHSE:688677)</h2><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p><p><strong>Overview:</strong> Qingdao NovelBeam Technology Co., Ltd. specializes in the research, development, production, and sales of medical endoscopic instruments and optical products globally, with a market cap of CN¥5.67 billion.</p><p><strong>Operations:</strong> Qingdao NovelBeam derives its revenue primarily from the sales and maintenance of endoscopes and optical-related products, amounting to CN¥602.61 million. The company's net profit margin is a key financial metric to consider when evaluating its profitability.</p><p>Qingdao NovelBeam Technology, a nimble player in the tech space, is showing promising signs with its price-to-earnings ratio at 37.8x, well below the CN market average of 45.2x. The company has demonstrated robust earnings growth of 26.8% over the past year, outpacing the medical equipment industry’s modest increase of 0.3%. With sales climbing to CNY 602.61 million from CNY 442.83 million and net income rising to CNY 171.6 million from CNY 135.35 million year-on-year, its financial health appears strong; this is further underscored by a debt-to-equity ratio reduction from 15.5% to 11.8% over five years and recent share buybacks totaling approximately CNY 58.99 million for about a combined total of around1 .33%, reflecting confidence in future prospects.</p><ul><li>Unlock comprehensive insights into our analysis of Qingdao NovelBeam TechnologyLtd stock in this health report.</li><li>Examine Qingdao NovelBeam TechnologyLtd's past performance report to understand how it has performed in the past.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/3fe5c722-b1a8-447c-a4a4-aa4b8dea55e7/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/3fe5c722-b1a8-447c-a4a4-aa4b8dea55e7/chart/earnings-and-revenue-growth"/><figcaption>SHSE:688677 Earnings and Revenue Growth as at Mar 2026</figcaption></figure><h2>Shandong Sacred Sun Power SourcesLtd (SZSE:002580)</h2><p><strong>Simply Wall St Value Rating:</strong> ★★★★★☆</p><p><strong>Overview:</strong> Shandong Sacred Sun Power Sources Co., Ltd is engaged in providing green energy solutions globally and has a market capitalization of approximately CN¥7.27 billion.</p><p><strong>Operations:</strong> The company generates revenue primarily from its industrial segment, including batteries, amounting to approximately CN¥3.36 billion.</p><p>Shandong Sacred Sun Power Sources Ltd., a nimble player in the electrical industry, has shown impressive growth with earnings rising 15.8% last year, outpacing the industry average of 5.7%. The company's debt-to-equity ratio slightly increased over five years from 17.9% to 19.2%, yet its interest coverage remains robust at 30 times EBIT, indicating strong financial health. With high-quality earnings and a price-to-earnings ratio of 40.1x below the China market average of 45.2x, it seems well-positioned for value seekers despite some leverage concerns in its capital structure.</p><ul><li>Click here to discover the nuances of Shandong Sacred Sun Power SourcesLtd with our detailed analytical health report.</li><li>Understand Shandong Sacred Sun Power SourcesLtd's track record by examining our Past report.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4281ccc6-9a0d-406b-8286-f95eb7e24479/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4281ccc6-9a0d-406b-8286-f95eb7e24479/chart/earnings-and-revenue-growth"/><figcaption>SZSE:002580 Earnings and Revenue Growth as at Mar 2026</figcaption></figure><h2>Seize The Opportunity</h2><ul><li>Take a closer look at our Global Undiscovered Gems With Strong Fundamentals list of 3100 companies by clicking here.</li><li>Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.</li><li>Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.</li></ul><h2>Curious About Other Options?</h2><ul><li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li><li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li><li>Find companies with promising cash flow potential yet trading below their fair value.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.</em></p><div><h3><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>• Connect an unlimited number of Portfolios and see your total in one currency<br/>• Be alerted to new Warning Signs or Risks via email or mobile<br/>• Track the Fair Value of your stocks<br/></p><p>Try a Demo Portfolio for Free</p></div></div></div>

AVUV

IWMI

<p>In March 2026, global markets are experiencing mixed performances due to geopolitical tensions and fluctuating energy prices. While large-cap stocks are under pressure, small- and mid-cap indexes like the S&P MidCap 400 and Russell 2000 show resilience, presenting opportunities for investors. A list of top 10 undiscovered gems with strong fundamentals includes companies like Aurisco Pharmaceutical, Qingdao NovelBeam Technology, and Shandong Sacred Sun Power Sources, all demonstrating robust financial health and growth potential. Investors are encouraged to explore these stocks for long-term growth amidst economic uncertainties.</p>

- In March 2026, global markets experienced mixed performances due to geopolitical tensions and fluctuating energy prices, with small- and mid-cap stocks showing resilience.  
- Several companies, classified as "undiscovered gems," exhibited strong fundamentals despite market pressures, with Aurisco Pharmaceutical and Qingdao NovelBeam Technology highlighting robust earnings growth and attractive valuations.  
- The article emphasizes the importance of identifying stocks with strong fundamentals for potential long-term growth amid economic uncertainties.

Undiscovered Gems in Global Markets for March 2026